Pnc Financial Services Group, Inc. Phathom Pharmaceuticals, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $156 Billion
- Q3 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Phathom Pharmaceuticals, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 273 shares of PHAT stock, worth $2,033. This represents 0.0% of its overall portfolio holdings.
Number of Shares
273
Previous 151
80.79%
Holding current value
$2,033
Previous $1,000
300.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding PHAT
# of Institutions
144Shares Held
73.6MCall Options Held
42.3KPut Options Held
45.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA10.1MShares$75.3 Million9.84% of portfolio
-
Medicxi Ventures Management (Jersey) LTD7.46MShares$55.6 Million28.04% of portfolio
-
Jennison Associates LLC5.87MShares$43.7 Million0.07% of portfolio
-
Invesco Ltd. Atlanta, GA4.1MShares$30.5 Million0.01% of portfolio
-
Carlyle Group Inc. Washington, DC3.5MShares$26.1 Million9.52% of portfolio
About Phathom Pharmaceuticals, Inc.
- Ticker PHAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,175,200
- Market Cap $292M
- Description
- Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...